Acquire the license to the best health content in the world
Contact Us

New Weapon Against Yeast Infections Found

Peptide molecule may offer alternative treatment for common vaginal problem

WEDNESDAY, May 26, 2004 (HealthDayNews) -- Millions of women who have suffered through yeast infections might welcome this news: Another treatment for the common condition is on the horizon.

Positive trial results for the peptide molecule CZEN-002 for treatment of vaginal yeast infection were announced this week by Zengen Inc.

The open label, non-randomized study of 20 women with yeast infections (17 completed the study) evaluated the safety, tolerability and pharmacokinetics of CZEN-002. The study found that five days of treatment provided evidence of its efficacy.

The trial results also indicated that CZEN-002 is safe and well-tolerated, with no severe adverse reactions among the study volunteers.

"This trial clearly established the efficacy of CZEN-002," lead investigator Dr. William Smith, an associate professor of clinical medicine at Tulane University School of Medicine and Louisiana State University Medical Center, said in a prepared statement.

"The encouraging results provide hope that this compound may become a new treatment option for the millions of women diagnosed each year" with yeast infections, Smith said.

More information

The U.S. National Library of Medicine has more about vaginal yeast infection.

SOURCE: Zengen Inc., news release, May 26, 2004
Consumer News